141 related articles for article (PubMed ID: 20198737)
1. Getting personal. Advances in biotechnology and the promise of personalized medicine help drive record investment in 2009.
Vesely R
Mod Healthc; 2010 Feb; 40(5):26-8. PubMed ID: 20198737
[No Abstract] [Full Text] [Related]
2. In tough times, personalized medicine needs specific partners.
Ballantyne C
Nat Med; 2008 Dec; 14(12):1294. PubMed ID: 19057535
[No Abstract] [Full Text] [Related]
3. Personalized medicine for patients with asthma.
Greenberger PA
J Allergy Clin Immunol; 2010 Feb; 125(2):305-6. PubMed ID: 20159238
[No Abstract] [Full Text] [Related]
4. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
5. Personalized medicine - the promised land: are we there yet?
Li C
Clin Genet; 2011 May; 79(5):403-12. PubMed ID: 21204795
[TBL] [Abstract][Full Text] [Related]
6. Can personalized drugs pay off?
Stipp D
Fortune; 2002 May; 145(10):168. PubMed ID: 12025349
[No Abstract] [Full Text] [Related]
7. A piece in the puzzle of personalized medicine.
Kroemer HK; Meyer zu Schwabedissen HE
Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
[TBL] [Abstract][Full Text] [Related]
8. Stuck in the middle.
Fuyuno I
Nature; 2006 Jul; 442(7100):237. PubMed ID: 16855561
[No Abstract] [Full Text] [Related]
9. Personalized medicine: will dentistry ride the wave or watch from the beach?
Kornman KS; Duff GW
J Dent Res; 2012 Jul; 91(7 Suppl):8S-11S. PubMed ID: 22699674
[TBL] [Abstract][Full Text] [Related]
10. Investment indicators show US is still ahead.
Lähteenmäki R; Hodgson J
Nat Biotechnol; 1998 Feb; 16(2):149-50. PubMed ID: 9487519
[No Abstract] [Full Text] [Related]
11. [Personalized treatment of cancer: utopia or chance?].
Thiel E
Dtsch Med Wochenschr; 2010 Sep; 135(38):1851. PubMed ID: 20842603
[No Abstract] [Full Text] [Related]
12. White biotechnology: ready to partner and invest in.
Kircher M
Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821
[TBL] [Abstract][Full Text] [Related]
13. The promise of personalized medicine: regulatory controls and tort influences in the context of personalized risks and benefits.
Prebula RJ
J Contemp Health Law Policy; 2010; 26(2):343-72. PubMed ID: 20662360
[No Abstract] [Full Text] [Related]
14. Achieving the promise of personalized medicine.
Reynolds KS
Clin Pharmacol Ther; 2012 Oct; 92(4):401-5. PubMed ID: 22992663
[TBL] [Abstract][Full Text] [Related]
15. Getting personal.
Anderson HJ
Health Data Manag; 2010 Feb; 18(2):30-1, 33-4, 36-7. PubMed ID: 20180454
[No Abstract] [Full Text] [Related]
16. Patient-centric clinical pharmacology advances the path to personalized medicine.
Waldman SA; Terzic A
Biomark Med; 2011 Dec; 5(6):697-700. PubMed ID: 22103605
[No Abstract] [Full Text] [Related]
17. Japanese firms broaden investment focus to early biotech.
Louët S; Sipp D
Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
[No Abstract] [Full Text] [Related]
18. Getting personal: the promises and pitfalls of personalized medicine.
Laurence J
Transl Res; 2009 Dec; 154(6):269-71. PubMed ID: 19931191
[No Abstract] [Full Text] [Related]
19. There's still gold in them thar pills.
O'Reilly B
Fortune; 2001 Jul; 144(2):58-62, 66-8, 70. PubMed ID: 11471355
[No Abstract] [Full Text] [Related]
20. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
